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ABSTRACT
Mammalian tissue- and/or time-specific transcrip-
tion is primarily regulated in a combinatorial fashion
through interactions between a specific set of
transcriptional regulatory factors (TRFs) and their
cognate cis-regulatory elements located in the reg-
ulatory regions. In exploring the DNA regions and
TRFs involved in combinatorial transcriptional regu-
lation, we noted that individual knockdown of a set
of human liver-enriched TRFs such as HNF1A,
HNF3A, HNF3B, HNF3G and HNF4A resulted in per-
turbation of the expression of several single TRF
genes, such as HNF1A, HNF3G and CEBPA genes.
We thus searched the potential binding sites for
these five TRFs in the highly conserved genomic
regions around these three TRF genes and found
several putative combinatorial regulatory regions.
Chromatin immunoprecipitation analysis revealed
that almost all of the putative regulatory DNA regions
were bound by the TRFs as well as two coactivators
(CBP and p300). The strong transcription-enhancing
activity of the putative combinatorial regulatory
region located downstream of the CEBPA gene
was confirmed. EMSA demonstrated specific bind-
ings of these HNFs to the target DNA region.
Finally, co-transfection reporter assays with various
combinations of expression vectors for these HNF
genes demonstrated the transcriptional activation
of the CEBPA gene in a combinatorial manner by
these TRFs.
INTRODUCTION
In mammals, tens of thousands of protein-coding and
nonprotein-coding genes are diﬀerentially expressed in
speciﬁc cell types, during development, in the process of
diseases and in response to various extracellular signals
(1). Accumulating evidence indicates that the com-
plex transcriptional regulatory patterns of mammalian
genes are mediated via interactions of a set of transcrip-
tional regulatory factors (TRFs) with their cognate cis-
regulatory elements (2,3) (combinatorial transcriptional
regulation). Combinatorial arrangement of multiple
TRFs allows cells to ﬁnely control gene transcription
and integrate multiple signal transduction pathways
(4,5). Therefore, identiﬁcation of the set of TRFs and
their binding sites is essential for understanding the mech-
anism of combinatorial transcriptional regulation relevant
to the biological event in question.
Current approaches to predicting and/or identifying
combinatorial transcriptional regulatory sites have
stemmed from coexpression analysis of TRFs and their
target genes in a given tissue or cell, TRF-chromatin bind-
ing analysis and a computational search for possible TRF
binding sites (TFBSs). Although several combinations of
these methods and criteria can be applied to probe regu-
latory sites, highly reliable methods are needed to identify
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combinatorial regulation of a given gene.
In contrast to the proximal regulatory region located
near the transcription start site (TSS) of each gene to be
regulated, the distal regulatory regions such as enhancers
and locus control regions (LCRs) are located at 50-o r3 0-
ﬂanking regions, intronic or even intergenic regions, which
have often a few hundred kilo base pairs distant from the
core promoter of the regulated gene (6,7), requires sophis-
ticated strategies for their probing. Recent work has con-
ﬁrmed that, in general, individual TFBSs are conserved
more than their surrounding DNA (8) and thus conserved
noncoding sequences are good candidates for transcrip-
tional regulatory elements (9). Hence, evolutionary
sequence conservation has been recognized as an informa-
tive indicator of biological signiﬁcance (10).
Another critical issue is to identify the TRFs engaged in
combinatorial regulation. Knockdown of a speciﬁc TRF
gene leads to perturbation of expression of its downstream
genes and hence is a powerful search method (11–13).
We have recently performed RNAi experiments in which
TRF genes in a group are individually knocked down by
speciﬁc respective siRNAs and the changes in their expres-
sion levels are quantiﬁed (submitted for publication). In
these experiments, several TRF genes were simultaneously
down- or upregulated accompanied by knockdown of
each of a set of several TRFs. This ﬁnding suggested
that it might be possible to predict the TRFs involved in
combinatorial regulation of a given gene by examining its
coincidental perturbation upon individual RNAi knock-
down of a set of TRF genes.
Here, we present a successful application of this
approach in combination with conventional approaches
such as bioinformatic and TRF location analysis to
characterize the combinatorial regulation of human TRF
gene transcription. This approach led to detection of both
known and/or novel combinatorial regulatory sites, which
were targeted by several liver-enriched TRFs [HNF1A,
HNF3A (FOXA1, HGNC symbol), HNF3B (FOXA2),
HNF3G (FOXA3) and HNF4A] in the three liver-
enriched TRF genes, HNF1A, CEBPA and HNF3G.
The transcription-enhancing activity of and the speciﬁc
TRF bindings to the deduced combinatorial regulatory
region that was located downstream of the CEBPA gene
were demonstrated by luciferase reporter assays, EMSA
and co-transfection reporter assays.
MATERIALS AND METHODS
Cells and medium
HepG2 cells were obtained from the Japanese Collection
of Research Bioresources (Osaka, Japan) and cultured in
Minimum Essential Medium Eagle (Sigma, St Louis, MO)
with 1mM sodium pyruvate (Sigma) supplemented with
10% fetal bovine serum at 378C in a 5% CO2 and 95%
atmosphere(13).
Prediction of combinatorial transcriptional regulatory sites
To search for the potential TFBSs, we used PReMod
(genomequebec.mcgill.ca/PReMod), a cis-regulatory
module (CRM) prediction database (14,15), and rVISTA
2.0(/rVISTA.dcode.org/), a tool for analyzing the regula-
tory potential of noncoding sequences (16,17). We
restricted our search for CRMs to regions that did not
overlap with other target genes. HNF1A and 1B share
the same recognition sequences. Similarly, HNF3 family
members (3A, 3B and 3G) and HNF4 family members
(4A and 4G) recognize their respective cognate sequences.
In PReMod analysis, we searched for CRMs containing
the HNF1, HNF3, HNF4 matrices in the region that
PReMod database predicted on each of the target gene
loci (HNF1A, NM_000545; HNF3G, NM_004497;
CEBPA, NM_004364). In the PReMod analysis, putative
human TFBSs are scored based on orthology with mouse
and rat genomic sequences, which is assessed by the
Multiz program (18).
We used precomputed pairwise alignments between
human (hg17) and mouse (mm7) genomes available
from the ECR Browser and GALA database (19–21) to
extract the evolutionary conserved regions. In the con-
served regions extracted, TFBSs that showed more than
90% sequence similarity were selected by rVISTA. To
probe the TRF binding modules with rVISTA, we
used a matrix similarity threshold of 0.85 for all of the
HNF1, HNF3 and HNF4 matrices in the TRANSFAC
v10.4 MATCH program (22,23). The used matrices were
as follows: V$HNF1_01, V$HNF1_C, V$HNF1_Q6,
V$HNF1_Q6_01, V$HNF1_C, V$HNF3ALPHA_Q6,
VHNF3B_01, V$HNF3_Q6, V$HNF3_Q6_01,
V$HNF4_01, V$HNF4_01_B, V$HNF4ALPHA_Q6,
V$HNF4_DR1_Q3 for HNF1, HNF3, and HNF4,
respectively. We selected regions including more than
two kinds of TRF matrix in the target ones predicted by
either of the two tools as potential combinatorial regula-
tory sites.
X-ChIP/qPCR
The HepG2 cell line was cultured to 70–80% conﬂuency in
MEM supplemented with 10% FBS and 1 10
8 cells were
ﬁxed with 1% formaldehyde at room temperature for
10min. The reaction was stopped by incubation with
125mM glycine for 5min. The ﬁxed cells were washed
twice with PBS and resuspended in LB1 buﬀer as pre-
viously reported (24,25). After treatment with LB2
buﬀer, the cell pellets were resuspended in 5ml of LB3
buﬀer. The resultant lysate was placed on ice and soni-
cated for 10min with BranSon 450 Soniﬁer equipped with
a cup horn ﬁlled with cold water (48C) at 100% duty cycle.
This yielded DNA fragments of 500bp average length.
The sonicated sample was diluted 2-fold with LB3 buﬀer
and incubated at 48C overnight with 5mg of each of the
TRF-speciﬁc antibodies (Santa Cruz Biotechnology,
Inc., Santa Cruz, USA): HNF1A (sc-6547), HNF3A (sc-
22841), HNF3B (sc-9187), HNF3G (sc-5361), HNF4A
(sc-6556) and CBP (sc-369) and p300 (sc-584). All of
these antibodies have been reported to be eﬀective for
X-ChIP experiments (24,26–29). Fifty microliters of
protein-G magnetic beads (Dynal AS, Oslo, Norway)
were added to the chromatin-antibody mixture and incu-
bated for 2h. The magnetic beads were washed once with
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with LiCl wash buﬀer and twice with TE buﬀer as pre-
viously reported (30). The chromatin–antibody complexes
were eluted twice with 1% SDS and 100mM NaHCO3
at room temperature by 20-min vortexing and then
mixed with 20ml of 5M NaCl. Reversal of the crosslinking
and treatments with RNase and then proteinase K were
carried out as previously described (11,30). The DNA
samples were puriﬁed twice with phenol–chloroform–
isoamylalcohol and chloroform–isoamylalcohol, and
then the puriﬁed DNA was precipitated by isopropanol.
The puriﬁed DNA was dissolved in 150ml of distilled
water for the qPCR reaction.
PCR primer sequences are described in Supplementary
Table 1. All the primers were designed by Primer 3 (31).
The DNA segments (2ml) were quantiﬁed by qPCR in a
10-ml reaction mixture containing SYBR green perfect
real-time PCR mix (Takara, Japan) in an ABI 7500 fast
system (ABI). PCR reaction was carried out on an ABI
PRISM 7500 Fast real-time PCR System (Applied
Biosystems) by denaturation at 958C for 10s, followed
by running at 958C for 3s and 62.58C for 20s for 40
cycles. As controls, we ampliﬁed 1ng of input DNA and
an exon of the human GAPDH gene was ampliﬁed.
The enrichment of the DNA fragments corresponding
to the TRF binding regions was evaluated in triplicate
by calculating CT values as follows. The diﬀerence
(CTsample) in CT values observed with input DNA
(1ng of chromatin DNA) and with the immunoprecipi-
tates obtained by ChIP in the qPCR by using the tar-
get site-speciﬁc primers was ﬁrst calculated. Similarly,
the diﬀerence in CT values (CTcalibrator) was calcu-
lated by subtracting the CT observed with input DNA
from CT observed with ChIP sample by using the calibra-
tor (GAPDH)-speciﬁc primers. Finally, the diﬀerence
between CTsample and CTcalibrator (CT) was
calculated. We carried out three independent experiments
for each region with duplicate PCR reactions. The thresh-
old criteria used were CT 1, average CT 2 
standard deviation (SD) and P-value <0.05 in Student’s
t-test.
Comparative PCR
Puriﬁed DNA from X-ChIP as in X-ChIP/qPCR methods
was used for comparative PCR with speciﬁc primers
(CEBPA_4) described in Supplementary Table 1 to
amplify the fragments containing our putative region.
PCR was conducted in a mixture containing 5ml of pur-
iﬁed DNA (totally 150ml) or input DNA in several dilu-
tions, 0.2mM of each primer, 1mM dNTP mixture,
1.5mM MgCl2 and 1.25U of Ex Taq DNA polymerase
(Takara) in a total volume of 50ml. The PCR condition
was as follows: a denaturation by 958C for 30s followed
by 958C for 10s and 688C 30s for 25 to 40 cycles in step-
wise to check the optical PCR cycles. Ampliﬁed DNA
(34 cycles) was electrophoresed in a 3% agarose gel.
The precipitates obtained without antibodies (no anti)
and genome DNA (input) with several dilutions were
also used for PCR ampliﬁcation as the controls.
ChIP–chip analysis
We used 3 10
6 cells of HepG2 cells for X-ChIP with
10mg of HNF3A/B antibody (sc-6553). Ampliﬁcation,
hybridization with an Aﬀymetrix tiling array (GeneChip
Chromosome 21/22 1.0 Array Set, c-chip), and data
extraction protocol were previously described (32). In
qPCR experiments, 1ng of the X-ChIP samples and 1ng
of the input chromatin samples were used for ampliﬁca-
tion of the target DNA regions with speciﬁc primer sets.
The enrichment of DNA fragments (CT) was calculated
by subtracting the CT observed with the ChIP sample
from CT with the input chromatin DNA. A total of 35
HNF3 binding sites with a P-value <10
–4 were assigned to
the conserved and nonconserved DNA regions on a part
of the human chromosomes 22. For the sequence align-
ment to ﬁnd conserved regions meeting criteria for the
conservation (minimal identity of 70% in minimum
length of 100bp), the ECR browser (19) was used.
Luciferase reporter assayand co-transfection assay
The CEBPA promoter region (–426 to +7 relative
to the transcription start site) was ampliﬁed by PCR
from HepG2 genomic DNA using promoter_
XhoI_f (50-AAACTCGAGGACTCCATGGGGGAGTT
AGAG-30) ﬂanked by an XhoI site and promoter_SacI_r
(50-AAAGAGCTCTAGGGCAGGCAGGAGGAG-30)
ﬂanked by a SacI site as primers. PCR parameters con-
sisted of 5-min incubation at 958C for denaturation, fol-
lowed by 30 cycles of 958C for 30s and 688C for 30s using
KOD-Plus- (TOYOBO) with a ﬁnal concentration of 2%
DMSO. PCR products were electrophoresed in agarose
gels and puriﬁed. After digestion of the PCR product by
XhoI and SalI, the fragment was ligated to the luciferase
gene in pGL4.12 [luc2CP] Vector (Promega) to construct a
‘promoter vector’. To construct the plasmid for estimating
the enhancing activity of the combinatorial regulatory
region (CEBPA_4; +26094–+26416, relative to the
TSS) deduced, we placed it downstream of the reporter
gene that was expressed under The deduced regulatory
region was ampliﬁed by PCR using infusion_f (50-AAA
TCGATAAGGATCCTCCACCTCAGCAGCAAAG-30)
and infusion_r (50-ATCGGTCGACGGATCGTGGGGA
AAGACGATGTCAG-30) as primers and KOD-Plus-.
The thermal proﬁle for PCR was 958C for 5min, followed
by 30 cycles of 958C for 30s and 688C for 30s. The PCR
product (353bp) was puriﬁed as described above and
cloned into the BamHI site of the ‘promoter vector’
using In-Fusion PCR Cloning Kit (ClonTech) so as to
be ﬂanked by the end of the luciferase gene to construct
a ‘promoter-enhancer vector’. To generate three kinds of
mutant ‘promoter-enhancer vectors’ for each of the
HNF1, 3, 4 putative binding sites we used GeneTailor
TM
Site-Directed Mutagenesis System (Invitrogen). All of the
primer sequences used for mutagenesis are described in
Supplementary Table 2. Every mutant was sequenced for
veriﬁcation.
Luciferase reporter assays were performed in HepG2
cells. Cells (1 10
4) were seeded onto each well of
96-well plates and transfected with 200ng of the plasmids
on the following day using Lipofectamine2000
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and the luciferase activities were determined by a lumin-
ometer using Steady-Glo Luciferase Assay System
(Promega).
Human HNF1A, HNF3B, HNF4A cDNAs were PCR
ampliﬁed from HepG2 transcripts and cloned into NheI
site of pcDNA3.1(+) vector (Invitrogen) using In-Fusion
PCR Cloning Kit (ClonTech). Positive clones were
sequenced for veriﬁcation. Co-transfection assays were
performed in HeLa cells. Cells (1 10
4) were seeded
onto each well of 96-well plates and transfected with
200ng of the ‘promoter-enhancer vector’ and various
combinations of HNF expression vectors for HNF1A,
HNF3B, and HNF4A (50ng) or pcDNA3.1(+) vector
without any insert (control) with Lipofectamine2000
(Invitrogen) on the following day. Cells were harvested
48h after transfection and the luciferase activities were
determined as described above.
Electrophoretic mobility shiftassay(EMSA)
Nuclear extracts were prepared from HepG2 cells by using
the NE-PER nuclear and cytoplasmic extraction reagent
according to the manufacturer’s protocol (Pierce). The
total protein concentration was determined by the
Bradford assay (Bio-Rad) with BSA as standard. EMSA
was performed with a series of double-stranded (ds-)
oligonucleotides containing all (70bp) or some of the
HNF1, HNF3 and HNF4 recognition sequences derived
from the deduced CEBPA combinatorial regulatory
region (Supplementary Table 2) as probes. The 70-bp
probe was PCR-ampliﬁed with a speciﬁc primer set
(Supplementary Table 2) and puriﬁed by gel extraction.
Mutant oligonucleotides that had the same nucleotide
substitutions as those tested in the luciferase assay were
used as competitive inhibitors. In addition, the consensus
binding sequences for HNF1, HNF3 and HNF4 (33) were
prepared to be used as additional speciﬁc competitors.
To obtain ds-oligonucleotides, two complementary
oligonucleotides (2.5mM each) were annealed by heating
at 808C for 10min and slowly cooling down to
room temperature. Annealed ds-oligonucleotides were
50-end-labeled at 378C for 2h in the reaction mixture
(20ml) containing 1  T4 polynucleotide kinase (PNK)
buﬀer (Takara), 0.25mM ds-oligonucleotides or
70-bp probe, 0.74 MBq [g-
32P]ATP (111 TBq/mmol),
10U of T4 PNK. The labeled probes were puriﬁed by
using Nick columns(GE Healthcare). Approximately
5mg of the nuclear extracts were incubated for 30min at
room temperature (for 1h at 48C for the EMSA with
HNF4 probes) in 1  binding buﬀer containing 20mM
HEPES (pH 7.9), 12% glycerol, 40mM KCl, 2mM
EDTA, 0.5mM DTT, 0.5mg of poly (dI–dC) and the
labeled probe (0.05 pmol) in a ﬁnal volume of 10ml. In
competition or supershift assays, 100-fold molar excess of
cold (non-labeled) ds-oligonucleotides or 4mg of the spe-
ciﬁc antibody raised against each of the HNFs (described
in X-ChIP/qPCR) were added. The incubation mixtures
were electrophoresed at 48C on 7% polyacrylamide Tris–
glycine gels, which were precooled at 48C, at 200V for
2.5–3h (at 300V for 80min for the EMSA with HNF4
probes). Gels were dried, exposed to BAS2000 ﬁlters
with BAStation software (Fuji Photo Film, Kanagawa,
Japan).
RESULTS
Prediction ofmultiple TRF bindingregions
In our recent study on RNAi knockdown of liver-enriched
TRFs, we observed that suppression of liver-enriched
TRFs (HNF1A, HNF3A, HNF3B, HNF3G and
HNF4A) induced clear downregulation of HNF1A,
HNF3G and CEBPA genes in HepG2 cells (submitted).
Because such multiple inputting hubs appear to be a good
indicator of combinatorial transcriptional regulation, a set
of these TRFs and TRF genes were chosen for the subse-
quent analysis. Various experimental and computational
studies have suggested that conserved noncoding
sequences are good candidates for transcriptional regula-
tory elements (17). To test this, we ﬁrst analyzed the in vivo
binding of HNF3A/HNF3B as a model by using a tiling
array.
A ChIP–chip experiment with an antibody speciﬁc for
HNF3A/HNF3B detected 35 peaks (sites) in a 35-Mb
region, a portion of the human chromosome 22, with
a P-value<10
–4. We then compared the enrichment
between DNA fragments in the X-ChIP immunoprecipi-
tates derived from the conserved regions and those from
the nonconserved regions with qPCR. Proper primers
could not be designed for two out of the 35 sites.
Human–mouse genome comparison analysis revealed
that 19 and 14 sites were located in a conserved and a
nonconserved region, respectively, and mostly in intronic
as well as intergenic conserved regions. Figure 1 clearly
shows more enrichment of DNA fragments from the con-
served regions over those from the nonconserved regions
with the P-value of 0.009 for the paired t-test. This ﬁnding
drove us to develop a system for identifying regulatory
sites including combinatorial regulatory ones in evolutio-
narily conserved noncoding regions in the human genome.
Next, we analyzed the potential HNF binding sites in
the DNA regions conserved in and around the human
HNF1A, HNF3G and CEBPA genes. Many prediction
tools have been developed for searching the TFBSs
in combination with genomic conservation analysis.
Among the currently available tools, we ﬁrst compara-
tively examined two methods, PReMod and rVISTA, to
predict the combinatorial regulatory regions because both
data sets are not restricted to modules or regions located
proximal to genes, but mostly contain distal predicted
CRMs or regions. Both PReMod and rVISTA use posi-
tion weight matrices (PWMs) of TRANSFAC for probing
TFBSs. PReMod is a database of genome-wide CRM pre-
dictions within the human genome and 481 TRANSFAC
version 7.2 PWMs for vertebrate TRFs are used to score
putative TFBSs based on how well the human site and
its orthologs in mouse and rat match the matrix (14,15).
rVISTA combines clustering of the predicted TFBSs and
analysis of interspecies sequence conservation to maximize
the identiﬁcation of functional regulatory sites (17). In
the present study, we used human- and mouse-genome
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combinatorial transcriptional regulation.
To predict the transcriptional regulatory regions by
PReMod, we used data sets of the UCSC hg17 human
genome assembly. We conducted locus-wide searches for
modules in the DNA regions of 98kb (chr12:
119804871-119903567 in hg17), 130kb (chr19:38408548-
38545500) and 20kb (chr19:51058207-51078705) that
were predicted by PReMod in or around each of
HNF1A, HNF3G, and CEBPA genes, respectively.
Next, we probed each module which included the consen-
sus matrices of HNF1, HNF3 and HNF4. In the rVISTA
analysis, we also checked the HNF1, HNF3 and HNF4
matrices in the conserved regions of the three target genes
that were predicted by the ECR Browser alignment anal-
ysis (see Materials and methods section).
The results of the analysis of TFBSs in the conserved
regions of the HNF1A, HNF3G and CEBPA genes are
summarized in Table 1. A typical transcriptional regula-
tory region, having three potential binding sequences for
the HNF1, HNF3 and HNF4, was predicted in the prox-
imal promoter of the HNF1A gene by both PReMod and
rVISTA (mod028501 and HNF1A_1). In addition, two
possible conserved regulatory regions were also detected
in the downstream regions of the HNF1A gene, and these
regions predicted by PReMod and rVISTA were consis-
tent with each other in terms of their locations and TFBSs
(mod028503 and HNF1A_2; mod028502 and HNF1A_4).
On the other hand, either PReMod or rVISTA detected
a set of potential regulatory regions around the CEBPA
gene but their respective locations were quite diﬀerent and
did not overlap with each other. PReMod detected three
potential regulatory sites: one is located in the upstream
region and the other two in the downstream region of the
human CEBPA gene (mod054831). rVISTA detected two
sites containing HNF3 and either HNF4 or HNF1 con-
sensus sequences in the downstream region of the CEBPA
gene (CEBPA_1, CEBPA_4).
Although PReMod did not detect any conserved region
containing potential sites for binding of the TRFs in and
around the HNF3G gene, rVISTA predicted a conserved
30-downstream region containing potential HNF1A and
HNF3 binding sites.
Table 1. Conserved DNA regions and HNF binding sites predicted in and around the human HNF1A, HNF3G and CEBPA genes
Predicted Validated Predicted Validated Validated Validated Predicted Validated Validated Validated Location
Gene Site HNF1 HNF1A HNF3 HNF3A HNF3B HNF3G HNF4 HNF4A CBP P300 from TSS (bp)
HNF1A HNF1AJ +++ ++++++ 441  +424
HNF1A4 +++ ++ +2176  +2508
mod028501 +++ ++++++ 459   99
mod028503 + + + +1059  +1161
mod028502 +++ ++ +2209  +2350
HNF3G HNF3GJ + + +++ + +9430  +9808
HNF3G 2 + + + +++ + + + +17703  +18018
CEBPA CEBPA_1 ++++++++++55013  +54674
CEBPA_4 +++ ++++++++26338  +26111
mod054825 + + + + +20066  +19896
mod054829 + + + + + +2666  +1978
mod054831 + + +  1230   1983
Both of PReMod and rVISTA were used to predict the HNF1A, FOXA and HNF4A binding sites in each of the evolutionary conserved regions. +
in the predicted TRF columns indicates that the potential TFBS was detected, – indicates no potential TFBS. + in the validated TRF and cofactor
columns indicates that chromatin binding was demonstrated, – indicates no signiﬁcant binding detected. Location relative to the TSS is indicated in
base pair.
Figure 1. Comparison of enrichment of HNF3A/HNF3B targets
between the TFBSs in the conserved and nonconserved regions on a
part of the human chromosome 22. ChIP–chip analysis was performed
by using an Aﬀymetrix tiling array (GeneChip Chromosome 21/22 1.0
Array Set, c-chip). A total of 33 sites that exhibited a P-value <10
–4
were detected and they were divided in two groups according to their
localization within conserved (19 sites) and nonconserved (14 sites)
regions. The conserved and nonconserved regions between human
and mouse genome were deﬁned by the analysis with zPicture
program, an option of the ECR browser. The enrichment of each
target site was assessed by X-ChIP/qPCR with speciﬁc primer sets mea-
suring CT, the diﬀerence between the threshold cycles observed with
input chromatin DNA (1ng) and with ChIP sample recovered by using
anti-HNF3 antibody recognizing HNF3A and HNF3B. The median,
upper and lower quartiles and minimum and maximum values of
CT are shown in the boxplot. The outlier value is plotted with a
small open circle.
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Next, we experimentally probed the combinatorial binding
of the HNF proteins to the conserved regions detected by
PReMod or rVISTA. For this purpose, we selected pre-
dicted regions containing at least two kinds of matrix for
the HNFs (HNF1A, HNF3s and HNF4A). Their bindings
to the predicted DNA regions were investigated by
X-ChIP/qPCR with speciﬁc antibodies against respective
HNFs. Because HNF3s share their binding sequence, we
used speciﬁc antibodies to discriminate chromatin bind-
ings among HNF3A, HNF3B and HNF3G. Target-
speciﬁc primer sets, each of which was able to amplify
the DNA region covering the TFBSs, were used for
qPCR. We also made primer sets to amplify the DNA
regions located  500bp downstream or upstream of the
target regions to evaluate the levels of nonspeciﬁc immu-
noprecipitation as the backgrounds.
All of the three conserved sites predicted by PReMod
overlapped with three out of four sites predicted by
rVISTA in the HNF1A proximal promoter and intronic
regions (Figure 2). Because all of these three overlapping
sites are located in an  3.9-kb DNA region, we examined
the HNF occupancy in this region with eight primer sets,
four of which were designed to cover each of the over-
lapping sites. X-ChIP/qPCR analysis revealed that all of
the HNFs (HNF1A, HNF3A, HNF3B, HNF3G and
HNF4A) were bound to the predicted site (mod028501
and HNF1A_1) in the proximal promoter of the
HNF1A gene (Figure 2). In addition, binding of all
HNFs, except HNF4A, to the farthest predicted site
(mod028502 and HNF1A_4) in the ﬁrst intron was also
detected (Figure 2). All of the binding data were consistent
with the predictions of the TFBSs made by both rVISTA
and PReMod. However, we did not detect signiﬁcant
binding of any of the HNFs to two other intronic sites.
No other transcript has been detected in the 130-kb
region encompassing the human CEBPA gene that has
no intron and the DNA region covering all the predicted
regulatory sites was extended more than 56kb. Thus, we
designed ﬁve groups of primer sets for X-ChIP/qPCR
analysis: each of the groups consisted of 3–4 primer sets
to amplify a 1.5–2.5-kb region containing any of the
potential regulatory sites. Only two (CEBPA_1 and _4,
predicted by rVISTA) out of the ﬁve CEBPA potential
regulatory sites predicted were found to be actually
bound by all of the HNFs examined (Figure 3A). These
sites are located  26- and 55-kb downstream of the
CEBPA TSS. The rVISTA prediction and the X-ChIP/
qPCR result at the +26-kb site completely coincided
with each other. Enrichment by X-ChIP of the DNA frag-
ments corresponding to this site was also conﬁrmed by
comparative PCR analysis (Figure 3B). Figure 4 shows
the nucleotide sequences of HNF1A_1 and CEBPA_4,
for both of which the rVISTA prediction and experimental
data are perfectly consistent with each other.
The X-ChIP/qPCR assay also showed the bindings of
all of the HNFs tested in a region about 17kb downstream
(HNF3G_2 in rVISTA analysis) from the TSS of HNF3G
gene (Figure 5). The DNA stretch corresponding to the
HNF3G_2 was a syntenic region that was previously
identiﬁed as an enhancer of the mouse HNF3G gene by
reporter assay in rat cultured cells (34).
CBPand p300 coincidentally bindto almost all thepredicted
conservedregions
Transcriptional regulation is known to be coupled
with TRF–cofactor interactions and cofactors can be
immunoprecipitated with DNA fragments derived from
Figure 2. HNFs (HNF1A, HNF3A, HNF3B, HNF3G and HNF4A)
occupancy analysis in proximal upstream region of and within the
human HNF1A gene. X-ChIP/qPCR analysis was carried out with spe-
ciﬁc primer sets covering each of the potential HNF binding sites
detected in the conserved regions. The enrichment of the target sites
was evaluated as the diﬀerences between CTsample and CTcalibrator
(CT) (see ‘Materials and methods’ section for the details). SD
values of the diﬀerences were calculated and the paired Student’s
t-tests were made to calculate P-values. The normalized mean CT
value is plotted against the nucleotide position at the center of each of
the corresponding DNA segments ampliﬁed (see Supplementary
Table 1 for details). The lowest CT was normalized to 0 in the
region of each TRF. Coincidental enrichment of the target sites with
antibodies speciﬁc to cofactors, p300 and CBP, was also assessed with
the same chromatin samples. In vivo bindings of HNF1A, HNF3B,
HNF3G, HNF4A, CBP and p300 to the
 1 region and HNF1A,
HNF3B and HNF3G to the
 2 region cleared the following criteria:
mean CT 1.0, mean CT 2  SD, and P<0.01. Base positions
are indicated at both sides of the chromosome fragment and beneath
the x-axes.
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dies (35). Thus, we next examined the coincidental immu-
noprecipitation of the DNA fragments, which were
derived from the sites that were strongly suggested by
RNAi knockdown, rVISTA prediction and X-ChIP–
qPCR analysis to be involved in the transcriptional regu-
lation of the three TRF genes, with well-known cofactors
CBP and p300. X-ChIP/qPCR assays clearly showed the
concomitant recovery of two cofactors with almost all of
these sites (ﬁve in six sites; Figures 2, 3 and 5; Table 1).
Based on the high probability of coincidental immunopre-
cipitation of the cofactor- and HNF-bound DNA frag-
ments, their common binding sites can be expected to
correspond to the potential combinatorial regulatory sites.
Overall, we identiﬁed four potential combinatorial reg-
ulatory sites that had binding matrices for all of the three
TRFs and were actually bound by these transcriptional
regulators (summarized in Table 1). TRF binding to all
but one of the 14 binding sites predicted by rVISTA were
experimentally conﬁrmed and three additional sites that
were not predicted were also detected. On the other
hand, 7 out of the 15 TFBSs predicted by PReMod were
bound by the cognate TRFs and two additional sites were
detected. Based on the superior prediction, rVISTA is
conclusively considered as the tool of choice for probing
the potential combinatorial regulatory sites.
Preferential TRFbinding to DNA regions withclustered
binding sites
We focused on the DNA regions where multiple (clus-
tered) HNF binding sites resided and identiﬁed their
Figure 3. HNFs occupancy analysis in upstream and downstream
regions of the human CEBPA gene. (A) The experimental setting is
the same as that in Figure 2. In the region with an asterisk, in vivo
bindings of HNF1A, HNF3A, HNF3B, HNF3G, HNF4A, CBP and
p300 cleared the criteria for enrichment as described in the footnote of
Figure 2. (B) DNA samples recovered from the X-ChIP as in (A) were
ampliﬁed by PCR and electrophoresed in a 3% agarose gel. The pre-
cipitates obtained without antibodies (no anti) and genome DNA
(input) were also used for PCR ampliﬁcation as the controls.
Figure 4. Nucleotide sequences of some of the putative combinatorial
regulatory regions identiﬁed. Sequence corresponding to the
TRANSFAC matrix for each TRF binding is indicated by boldface
in a rectangle. (A) HNF1A_1 (nucleotide number 1 corresponds to
 267 relative to the TSS); (B) CEBPA_4 (nucleotide number 1 corre-
sponds to +26278 relative to the TSS). The dotted line with arrows at
both sides shows the region used as the 70-bp probe in EMSA.
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On the other hand, a number of potential HNF binding
sites that are not clustered are found in the noncoding
regions in and around the HNF1A, HNF3G and CEBPA
genes. The question arises of whether these sites are bound
by each of the corresponding HNFs and involved in tran-
scriptional regulation. If this is the case, the DNA frag-
ments containing each of the single TFBSs should be
recovered with eﬃciencies comparable to those observed
for multiple TFBSs. We then examined the enrichment of
DNAfragmentsderivedfromtheCEBPAgeneinwhichwe
identiﬁed many single TFBSs as well as multiple TFBSs
focusing on HNF3s and HNF4A bindings.
rVISTA detected 18 sites containing at least one HNF1,
HNF3 or HNF4 matrix in the 130-kb CEBPA gene locus:
14 sites having only a single HNF3 consensus sequence,
two sites having an isolated HNF4-recognizable sequence
and two sites having HNF3 and HNF4A recognizable
sequences (Table 2). We evaluated the enrichment of the
speciﬁc DNA fragments containing a multiple TRF site
or an isolated TRF site by calculating the CT values
(see ‘Materials and methods’ section). As a result, the
isolated binding sites for any of the TRFs examined
(HNF3A, HNF3B, HNF3G and HNF4A) exhibited less
enrichment of the corresponding DNA fragments than
those of multiple TFBSs (Figure 6). This indicates that
these TRFs are bound to the potential combinatorial reg-
ulatory sites more frequently than to the isolated TRF-
recognizable sites.
We also compared the occupancy of CBP and p300at
the isolated and multiple TRF sites and again found the
preferential binding of these cofactors at multiple sites
over the isolated TRF sites. More signiﬁcantly, the multi-
ple TRF bindings at sites CEBPA_5, 8 and 9 were not
computationally predicted but the X-ChIP/qPCR assay
with a combination of multiple TRFs and cofactor anti-
bodies clearly detected their bindings. These results indi-
cate much higher commitment of the regions with
clustered TFBSs to transcriptional regulation of mamma-
lian genes.
The novel putative combinatorial regulatory region ofthe
CEBPA genehas astrong transcription-enhancing activity
To examine the stimulatory activity of the putative com-
binatorial regulatory region deduced by DNA conserva-
tion, RNAi knockdown and X-ChIP experimental data,
we performed the luciferase reporter assay in HepG2 cells.
In the assay, the 433-bp DNA fragment corresponding to
the human CEBPA proximal promoter (–426 to +7) were
inserted in front of the ﬁreﬂy luciferase reporter gene
in the pGL4.12 reporter vector to construct a ‘promoter
vector’. We also made a ‘promoter-enhancer vector’ in
which the deduced regulatory region (CEBPA_4 and its
ﬂanking regions) was inserted at the end of the luciferase
reporter gene in the CEBPA promoter vector by In-fusion
cloning system (see ‘Materials and methods’ section for
the details). We used the pGL4.12 reporter vector without
any additional insertion as a negative control. Each of
these vectors was introduced into HepG2 cells and the
luciferase activity in the cell extracts was measured 48h
after transfection. As shown in Figure 7A, insertion of the
DNA fragment derived from the putative combinatorial
regulatory region in the CEBPA promoter vector induced
a dramatic increase in the luciferase gene expression.
The putative combinatorial regulatory region contains
the binding sites for three TRFs (HNF1, HNF3 and
HNF4). To evaluate the involvements of these TRFs in
the regulation of transcription through the CEBPA prox-
imal promoter, we generated various mutant vectors in
which the TFBS for any one of the three TRFs had a
set of nucleotide substitutions as follows: TGGCCAA
(m1), TGGCGAA (m2) and TGCCCAA (m3) instead of
TGATTAA in the HNF1 binding site; ATTGA (m1),
ATGGA (m2) and ACTCA (m3) for AAACA in the
HNF3 binding site; GATAATA (m1), GACAATA (m2)
and GAGAATA (m3) for GCCTTGA in the HNF4 bind-
ing site.
Figure 5. HNFs occupancy analysis in the 30-ﬂanking and far down-
stream regions of the human HNF3G gene. The experimental setting is
the same as that in Figure 2. In vivo bindings of HNF1A, HNF3A,
HNF3B, HNF3G, HNF4A, CBP and p300 to the
 1 region and the
only cofactors (CBP and p300) to the
 2 region cleared the enrichment
criteria as described in the footnote of Figure 2.
Nucleic AcidsResearch, 2009, Vol.37,No. 3 785Figure 6. Preferential HNF binding to the putative combinatorial regulatory sites of the human CEBPA gene. The putative combinatorial regulatory
sites (multi) correspond to the composite TFBSs 1 and 4 and the remaining 16 sites (single) to the isolated sites in Table 2. The enrichment of each
target site was assessed by X-ChIP/qPCR with speciﬁc primer sets measuring CT, the diﬀerence between the threshold cycles observed with input
chromatin DNA (1ng) and with ChIP sample recovered by using antibody raised against HNF3A, HNF3B, HNF3G or HNF4A. The median, upper
and lower quartiles and minimum and maximum values of CT are shown in the boxplot. Double-sided P-values for the Student’s paired t-tests
were 0.0007, 0.001, 0.0009 and 0.18 for the bindings of HNF3A, HNF3B, HNF3G and HNF4A, respectively.
Table 2. Prediction of composite and isolated potential HNF binding sites in the DNA region surrounding the human CEBPA gene and
experimental validation of their interactions with the corresponding HNF proteins
Predicted Validated Predicted Validated Validated Validated Predicted Validated Validated Validated
Gene Site HNF1 HNF1A HNF3 HNF3A HNF3B HNF3G HNF4 HNF4A CBP P300
CEBPA CEBPA_1 + + + + + + +
CEBPA_2 +
CEBPA_3 + + +
CEBPA_4 + ++++++ +++
CEBPA_5 + + + + +
CEBPA_6 + +
CEBPA_7 + + +
CEBPA_8 + + + +
CEBPA_9 + + + + + + + +
CEBPA_10 +
CEBPA_11 + +
CEBPA_12 +
CEBPA_13 +
CEBPA_14 +
CEBPA_15 + +
CEBPA_16 +
CEBPA_17 +
CEBPA_18 +
All of these HNF binding sites were predicted by rVISTA. CEBPA_1 and _4 were predicted to be composite TFBSs and the remaining sites were
predicted to be isolated ones. + indicates that the TFBSs were predicted or the TRF bindings were demonstrated.
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decrease in luciferase gene expression (Figure 7B). In par-
ticular, several mutants such as m1 and m3 for HNF1, m2
for HNF3 and m3 for HNF4 resulted in a dramatic reduc-
tion in the reporter gene expression by more than 70% as
compared with the regulatory region having the wild-type
nucleotide sequence. The lower but signiﬁcant level of
transcription-enhancing activity was observed when the
70-bp DNA fragment containing the binding sites for all
of the three TRFs was inserted in the same location as
where the CEBPA_4 region was, indicating the involve-
ment of this narrow region in transcriptional enhancing.
This result also implies the additive stimulatory eﬀects of
the surrounding region(s). Overall, the reporter assays
demonstrate that all of these three TRFs and their binding
sites are needed for the full transcription-enhancing activ-
ity of the regulatory region, consistent with the data
obtained by the RNAi knockdown and X-ChIP/qPCR
analysis.
EMSAsupportsspecificbindingsoftheHNFstotheputative
combinatorial regulatory region
We then investigated protein binding to their cognate rec-
ognition sites within the combinatorial regulatory region
of the human CEBPA gene by EMSA. Several shifted
bands were detected by gel electrophoresis and imaging
after incubation of the radiolabled 70-bp oligonucleotide
probe, which was derived from CEBPA_4 and covered all
of the potential HNF1, HNF4 and HNF3 recognition
sequences that were located in this order, with the nuclear
extracts of HepG2 cells (Figure 8A). The addition of the
unlabeled 70 mer markedly decreased the intensities of
most of the bands. Short oligonucleotides correspond-
ing to HNF 1 or 3 consensus recognition sequence also
reduced the intensities of the cognate shifted bands
(Figure 8A). Moreover, the addition of the speciﬁc anti-
body against either HNF1A or HNF3B formed a super-
shifted band. These results indicate the speciﬁc bindings of
HNF1A and HNF3B to their target sites. Contrary to
this, neither clear competition by a ds-oligonucleotide
competitor speciﬁc for HNF4A nor a supershift by anti-
HNF4A antibody was detected. However, two distinct
shifted bands were detected when a smaller probe
(21-mer) derived from CEBPA_4 and containing a
HNF4 core recognition sequence was used as the probe
(Figure 8B). The intensities of these two bands were
severely diminished in the presence of 100-fold excess
amount of the unlabeled probe with the same sequence.
No supershift by anti-HNF4 antibody with this short
probe was again observed as with the 70-mer probe.
Any of three kinds of competitor with diﬀerent mutations
in the HNF4 core sequence failed to diminish the intensi-
ties of the two retarded bands in contrast to the compet-
itor with the wild-type sequence.
When the smaller (21bp) oligonucleotides containing a
HNF1 or HNF3 recognition sequence derived from
CEBPA_4 were used as the probes, supershifted bands
(two for HNF1 and one for HNF3B) appeared by the
incubation with HNF1A- or HNF3B-speciﬁc antibody
as were the case for EMSA with the longer (70-bp)
probe (Figure 8C and D). All of the three mutant
sequences did not aﬀect the intensities of the distinct
retarded bands in the EMSA of HNF1. The competitor
containing only the HNF3 consensus sequence also
reduced markedly a shifted band. On the other hand,
the mutant competitors diﬀerently aﬀected the intensity
of the shifted band. The mutant m1 that reduced moder-
ately the luciferase gene expression showed a modest com-
petition. The m3 competitor that slightly reduced the
enhancing activity showed a clear competition, whereas
the shifted band was scarcely competed by the m2
mutant sequence that caused a dramatic reduction in luci-
ferase gene expression.
Figure 7. Transcription-enhancing activity of the CEBPA_4 regulatory
region. Three independent experiments were performed in triplicate
(n=9). (A) The empty pGL4.12 vector was used as the control. The
‘promoter vector’ designated as ‘Promoter’ was the construct having
an insertion of the CEBPA proximal promoter region in front of the
luciferase gene. The ‘promoter-enhancer vector’ designated as
‘Promoter + 30 regulatory region’ has an insertion of the deduced
regulatory region (CEBPA_4 region) located downstream of the
CEBPA gene and its surrounding region at the end of the luciferase
gene. Fold induction indicates the level of luciferase expression (mean
with a standard deviation) relative to that (= 1.0) detected with only
the ‘empty’ vector. (B) The luciferase gene expressions by the constructs
containing a diﬀerent mutated sequence (m1–m3) for each of the three
TFBSs (HNF1, HNF3 and HNF4) were comparatively examined.
Expression level is indicated (mean with a standard deviation) relative
to that caused by the ‘promoter-enhancer vector’ (taken as 100% here
for comparative purposes).
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Based on the ﬁndings that the three TRFs (HNF1A,
HNF3B and HNF4A) bind to the novel putative regula-
tory region in the downstream of the CEBPA gene and
RNAi knockdown of any of these TRFs results in the
downregulation of the gene, we expected that the region
may be involved in a combinatorial transcriptional regu-
lation. To demonstrate the combinatorial regulation of
the CEBPA gene transcription by these three TRFs, car-
rying a luciferase reporter gene into HeLa cells. The TRF
expression vectors were exogenously introduced into
HeLa cells in a combinatorial manner along with the
‘promoter-enhancer vector’, a ﬁreﬂy luciferase reporter
vector and the luciferase activities were measured at 48h
after co-transfection. HeLa cells were chosen as the hosts
suitable for the reporter assays because the three TRFs
were much less expressed in HeLa cells compared with
HepG2 cells (Genome Network Platform Viewer URL://
genomenetwork.nig.ac.jp/public/sys/gnppub/portal.do)
and the combinatorial eﬀects of the TRF genes, which
were exogenously expressed, were expected to be clearer.
We tested all combinations of the three TRFs for their
Figure 8. In vitro binding of HNFs to the regulatory region located downstream of the CEBPA gene. HepG2 nuclear extracts were incubated with
the 70-mer probe containing the recognition sequences for HNF1, HNF3 and HNF4 or each of the TRF-speciﬁc probes (control). Competition
assays were carried out with the equimolar (1 ), 10-fold (10 ) or 100-fold (100 ) molar ratio of unlabeled probes (comp.), each of the TRF-speciﬁc
consensus sequences (consensus) or mutated sequences of each of the TRF recognition sites (m1, 2 and 3). Speciﬁc antibody raised against each TRF
(HNF1A, HNF3A, HNF3B, HNF3G and HNF4A anti.) was used for supershift assay. (A) 70-mer probe, (B) HNF4-speciﬁc probe, (C) HNF1-
speciﬁc probe, (D) HNF3-speciﬁc probe. TRF-speciﬁc complexes are showed by arrows (!) and supershifted complexes are showed by arrows with
an asterisk ( !).
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tion of CEBPA gene. As shown in Figure 9, double trans-
fections gave a modest or poor level of transcriptional
enhancement. On the other hand, the highest reporter
gene activation was occurred by the triple transfection
with all of the three TRF expression vectors (statistically
signiﬁcant on paired t-test with P-value of 0.007). These
data demonstrate that these three TRFs (HNF1A,
HNF3B and HNF4A) act in a combinatorial manner for
transcriptional regulation of the CEBPA gene.
DISCUSSION
To identify DNA regions and a set of TRFs that are
involved in combinatorial regulation, we used a strategy
including several criteria closely connected to functional
deﬁnition of transcriptional regulation in mammalian sys-
tems. The combination of these criteria was found to be
eﬀective for identifying the functional combinatorial reg-
ulatory regions and regulators. Involvement of the TRFs
identiﬁed in combinatorial transcriptional regulation may
be also supported by the fact that the TRFs lie very close
to each other. For example, HNFs bound to HNF1A_1 or
CEBPA_4 should be located in their immediate vicinity
(Figure 4). These TRFs may interact directly with each
other or communicate through interaction with cofactors
such as CBP and p300 or mediator(s). Physical association
of CBP with HNF1A has been reported (36). In addition
of CBP, HNF1A also interacts with HNF4A (37), sup-
porting that the combinatorial regulation by HNF1A
and HNF4A takes place via the physical interaction
between these TRFs.
The HNF1A gene is known to be regulated by binding
to its proximal promoter region of HNF3B (38), HNF4A
(24) and HNF1A itself (39,40) in mammalian cultured
cells and by HNF3G in salmon (41). We found signiﬁcant
perturbation of HNF1A gene expression by RNAi knock-
down of HNF3A, HNF3B, HNF3G and HNF4A in
HepG2 cells (submitted). Binding of almost all of these
TRFs as well as CBP and p300at the proximal upstream
region (HNF1A_1 and mod028501) were clearly observed,
indicating the validity of the present approach for char-
acterizing combinatorial transcriptional regulation.
Because regulation of the HNF1A gene by a multiple
binding of HNF3s has not yet been reported, our ﬁndings
add new insights into the mechanism of regulation of the
mammalian HNF1A gene, whose heterozygous germ-line
mutations are linked to the occurrence of maturity-onset
diabetes of the young (MODY3) in humans (42). The
reason why only anti-HNF3B antibody caused the super
shift in contrast with the successful ChIP with all of the
antibodies against the three HNF3s is unknown. Another
region (HNF1A_4 and mod028502) showed clear bindings
of HNF1A, HNF3A, HNF3B and HNF3G, but its invol-
vement in the combinatorial transcriptional regulation of
HNF1A gene is not conclusive because no clear bindings
of HNF4A, CBP and p300 were detected.
CEBPA-mediated transcriptional regulation has been
extensively studied (43–45). However, the mechanism of
transcriptional regulation of the CEBPA gene itself
remains to be elucidated. We identiﬁed two regulatory
sites in the far downstream region of the CEBPA gene
and demonstrated that the coactivators and HNFs exam-
ined bind to that region. Especially, one of the regulatory
sites, CEBPA_4 that was bound by almost all of the HNFs
and coactivators in X-ChIP assays showed a strong
transcription-enhancing activity in the luciferase reporter
assays. Most of the mutations at the recognition sites
of HNF1, HNF3 and HNF4 in this region caused signif-
icant reduction in transcription-enhancing activities,
supporting the involvement of these TRFs in combinator-
ial transcriptional regulation through the bindings to
this enhancing region. EMSA also supported speciﬁc
bindings of all of HNF1, HNF3 (mainly HNF3B based
on the supershift) and HNF4 to this region. Although no
supershift by the HNF4-speciﬁc antibody was observed
with either the 70-mer or smaller probe, competition
by an unlabeled competitor and the supershift by the
same HNF4-speciﬁc antibody were clearly shown when
the HNF4 consensus sequence derived from human
Figure 9. Combinatorial regulation of the CEBPA gene by a set of the HNFs. Three independent experiments were performed in triplicate (n=9).
The ‘promoter-enhancer vector’, a luciferase reporter vector, and various combinations of HNF (HNF1A, HNF3B and HNF4A) expression vectors
or the control vectors were transfected into HeLa cells. Expression levels are indicated (mean with a standard deviation) relative to those achieved by
co-transfection with the control vector (taken as 100% here for comparative purposes). single, co-transfection with the reporter vector and expression
vectors for a single TRF gene; double, co-transfection with expression vectors for each of the two TRF genes; triple, co-transfection with all of the
three TRFs. As a control, we used the same amount of the control vectors for each co-transfection experiment. Asterisks (
  ) mean a statistically
signiﬁcant combination compared with the control data set. P-value was calculated by Student’s t-test (P-value <0.01).
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with the same nuclear extracts (data not shown).
Therefore, the extracts contained active HNF4 proteins
and the HNF4-speciﬁc antibody really had the TRF-bind-
ing potential as demonstrated in X-ChIP assays. Based on
the ﬁndings that the mutant sequences cannot inhibit the
band shifts as competitors but can induce a marked (m3)
and a pronounced (m2) reduction in enhancing the lucif-
erase gene expression in the reporter assays, it is reason-
able to think that HNF4 does not bind eﬃciently to these
mutant sequences but does to the wild-type sequence in
the form in which its epitope may be masked by some
other protein(s), which interact with HNF4 to prevent it
from binding of the HNF4-speciﬁc antibody. Interactions
of HNF4A with other transcription factors including
HNF1A and coactivators including CBP have been well
documented (37,46–49).
Finally, co-transfection assays with the expression vec-
tors for HNF1A, HNF3B and HNF4A genes along with
the luciferase reporter vector containing the CEBPA pro-
moter and novel regulatory region provided strong evi-
dence of their combinatorial transcriptional regulation
of the CEBPA gene. It should be noted that double trans-
fection of HNF3B and either HNF1A or HNF4A exhib-
ited a modest transcriptional stimulation and the
combination of HNF1A and HNF4A was scarcely eﬀec-
tive to enhance the CEBPA gene transcription. These data
suggest that the three TRFs are needed to act in a combi-
natorial manner for the attainment of full transcriptional
stimulation of their common target CEBPA gene. This is
consistent with the ﬁnding that RNAi knockdown of any
of these TRF genes resulted in a signiﬁcant reduction of
the levels of the CEBPA gene expression.
The transcriptional regulation of CEBPA gene is critical
for various biological events such as inhibition of mitotic
growth and tumor suppression (43–45). Information
about its distant regulatory sites and the TRFs involved
in the combinatorial regulation should provide insights
into the mechanism of its functioning in mammalian cells.
HNF3G is an essential TRF for the maintenance of
speciﬁc liver functions (50–52), but the mechanism of reg-
ulation of HNF3G gene expression remains poorly under-
stood. We found that HNF3G_2 site may be engaged in
the transcriptional regulation. Binding to this site by all
the HNFs and two coactivators examined was observed.
Although rVISTA could not locate any consensus
sequence for HNF4A recognition, a manual search led
us to detection of two possible HNF4A binding sequences
lying  300bp apart from each other within this site. A
portion of the HNF3G_2 is homologous to the enhancer
identiﬁed at +16kb of mouse HNF3G gene (34), also
supporting the validity of using the present approach to
identify distantly located mammalian enhancers.
In general, individual TFBSs are more conserved than is
their surrounding DNA, and genes having high sequence
conservation in their upstream regions are predominantly
TRF genes (8). If this is the case, the present approach
based on sequence conservation analysis can be eﬀectively
applied to the characterization of combinatorial regula-
tion of mammalian TRF genes. In conclusion, the present
approach could be eﬀectively used to identify TRFs and
their cognate cis-regulatory elements and to investigate
their involvements in combinatorial transcriptional regu-
lation leading to understanding of their regulatory
mechanisms.
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